Nab-PCE vs PC for MM After Failure of Anti-PD-1

NCT03917069 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma

Interventions

DRUG: Chemotherapeutic Combinations
DRUG: chemotherapy

Sponsor

Peking University Cancer Hospital & Institute